Circ-MBOAT2 Regulates Angiogenesis via the miR-495/NOTCH1 Axis and Associates with Myocardial Perfusion in Patients with Coronary Chronic Total Occlusion

Wei Gao,Chenguang Li,Jie Yuan,Youming Zhang,Guobing Liu,Jianhui Zhang,Hongcheng Shi,Haibo Liu,Junbo Ge
DOI: https://doi.org/10.3390/ijms25020793
IF: 5.6
2024-01-09
International Journal of Molecular Sciences
Abstract:Revascularization of coronary chronic total occlusion (CTO) still remains controversial. The factors that impact collateral circulation and myocardial perfusion are of interest. Circular RNA (circRNA) has been shown to regulate the process of angiogenesis. However, the effects of circ-membrane-bound O-acyltransferase domain containing 2 (circ-MBOAT2) on angiogenesis in patients with CTO were unclear. In this study, we evaluated circulating circRNAs and miRNAs in patients with CTO and stable coronary artery disease using high-throughput sequencing. Another cohort of patients were selected to verify the expressions of circ-MBOAT2 and miR-495. The role and mechanism of circ-MBOAT2 in the process of angiogenesis were explored through in vitro and vivo studies. Finally, we came back to a clinical perspective and investigated whether circ-MBOAT2 and miR-495 were associated with the improvement of myocardial perfusion evaluated by single-photon emission computed tomography (SPECT). We found that the expression of circ-MBOAT2 was significantly up-regulated while miR-495 was significantly down-regulated in patients with CTO. The expression of circ-MBOAT2 was negatively correlated with miR-495 in patients with CTO. In an in vitro study, we found that circ-MBOAT2 promoted tube formation and cell migration via the miR-495/NOTCH1 axis in endothelial cells. In an in vivo study, we showed that the inhibition of miR-495 caused the increase in collateral formation in mice after hindlimb ischemia. In a human study, we showed the expressions of circ-MBOAT2 and miR-495 were associated with myocardial perfusion improvement after revascularization of CTO. In conclusion, circ-MBOAT2 regulates angiogenesis via the miR-495/NOTCH1 axis and associates with myocardial perfusion in patients with CTO. Our findings suggest that circ-MBOAT2 and miR-495 may be potential therapeutic targets and prognostic factors for patients with CTO.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the expression and role of circular RNA (circRNA) in patients with chronic total occlusion (CTO) of the coronary artery, especially the regulatory mechanism of circ - MBOAT2 in the angiogenesis process and its relationship with myocardial perfusion. Specifically, the study aims to answer the following key questions: 1. **Expression of circ - MBOAT2 in CTO patients**: Researchers analyzed the expression profiles of circulating circRNAs and miRNAs in CTO patients and patients with stable coronary heart disease by high - throughput sequencing, and focused on the expression changes of circ - MBOAT2. 2. **Effect of circ - MBOAT2 on angiogenesis**: Researchers explored the specific effects of circ - MBOAT2 on angiogenesis through in vitro experiments (such as endothelial cell tube formation experiments and migration experiments) and in vivo experiments (such as mouse hind - limb ischemia models). 3. **Molecular mechanism of circ - MBOAT2 in regulating angiogenesis**: Researchers revealed the role of circ - MBOAT2 as a miR - 495 sponge and the regulation of miR - 495 on the NOTCH1 signaling pathway by methods such as dual - luciferase reporter gene assays and Western Blot. 4. **Relationship between circ - MBOAT2 and miR - 495 and myocardial perfusion**: Researchers evaluated the myocardial perfusion of CTO patients before and after revascularization by single - photon emission computed tomography (SPECT), and analyzed the association between the expression levels of circ - MBOAT2 and miR - 495 and the improvement of myocardial perfusion. ### Main findings - **Up - regulation of circ - MBOAT2 expression and down - regulation of miR - 495 expression**: In CTO patients, the expression of circ - MBOAT2 was significantly increased, while the expression of miR - 495 was significantly decreased, especially in patients with better collateral circulation. - **circ - MBOAT2 promotes angiogenesis**: In vitro experiments showed that over - expression of circ - MBOAT2 could promote the tube formation and migration of endothelial cells, while inhibition of circ - MBOAT2 had the opposite effect. - **miR - 495 inhibits angiogenesis through the NOTCH1 pathway**: The miR - 495 mimic inhibited the migration and tube formation of endothelial cells, while the miR - 495 inhibitor promoted these processes. In addition, miR - 495 exerts its effect by targeting NOTCH1. - **circ - MBOAT2 acts as a sponge for miR - 495**: circ - MBOAT2 up - regulates NOTCH1 expression by absorbing miR - 495, thereby promoting angiogenesis. - **circ - MBOAT2 and miR - 495 are related to the improvement of myocardial perfusion**: In CTO patients after revascularization, the expression of circ - MBOAT2 was higher and the expression of miR - 495 was lower in patients with improved myocardial perfusion. ### Conclusion This study shows that circ - MBOAT2 regulates angiogenesis through the miR - 495/NOTCH1 axis and is closely related to the improvement of myocardial perfusion in CTO patients. These findings suggest that circ - MBOAT2 and miR - 495 may be potential therapeutic targets and prognostic markers for CTO patients.